Beranda › Kelebihan Berat Badan
Uji klinis Kelebihan Berat Badan yang merekrut di AS
204 studi untuk Kelebihan Berat Badan merekrut peserta di lokasi di seluruh Amerika Serikat.
Kota dengan studi terbanyak
- San Antonio, TX34 studi
- Houston, TX33 studi
- Chicago, IL28 studi
- Orlando, FL27 studi
- Las Vegas, NV23 studi
- Miami, FL23 studi
- Atlanta, GA20 studi
- Dallas, TX20 studi
- Washington, DC19 studi
- New York City, NY19 studi
- Jacksonville, FL19 studi
- Austin, TX18 studi
- Havelock, NC17 studi
- Baltimore, MD17 studi
- Concord, CA16 studi
- Birmingham, AL16 studi
- Tucson, AZ15 studi
- Los Angeles, CA15 studi
- Charlotte, NC15 studi
- Louisville, KY15 studi
- St. Louis, MO15 studi
- Phoenix, AZ15 studi
- Johns Creek, GA14 studi
- Philadelphia, PA14 studi
- Cincinnati, OH14 studi
- Indianapolis, IN13 studi
- San Diego, CA13 studi
- Columbus, OH13 studi
- Rochester, NY13 studi
- Salt Lake City, UT13 studi
- Greensboro, NC12 studi
- Escondido, CA12 studi
- Boston, MA12 studi
- Wilmington, NC11 studi
- Honolulu, HI11 studi
- South Fulton, GA11 studi
- Arlington, VA11 studi
- Grand Prairie, TX11 studi
- Pittsburgh, PA10 studi
- The Woodlands, TX10 studi
Berdasarkan negara bagian
- Alabama31 studi
- Arizona29 studi
- Arkansas6 studi
- California64 studi
- Colorado11 studi
- Connecticut16 studi
- Distrik Columbia7 studi
- Florida55 studi
- Georgia36 studi
- Hawaii11 studi
- Idaho19 studi
- Illinois38 studi
- Indiana16 studi
- Iowa9 studi
- Kansas26 studi
- Kentucky21 studi
- Louisiana23 studi
- Maryland37 studi
- Massachusetts24 studi
- Michigan19 studi
- Minnesota13 studi
- Mississippi11 studi
- Missouri33 studi
- Montana6 studi
- Nebraska7 studi
- Nevada24 studi
- New Hampshire3 studi
- New Jersey16 studi
- New Mexico4 studi
- New York45 studi
- North Carolina40 studi
- North Dakota8 studi
- Ohio35 studi
- Oklahoma18 studi
- Oregon13 studi
- Pennsylvania32 studi
- Rhode Island13 studi
- South Carolina35 studi
- South Dakota4 studi
- Tennessee25 studi
- Texas55 studi
- Utah22 studi
- Virginia33 studi
- Washington23 studi
- Wisconsin8 studi
Studi yang baru diperbarui
Teks studi resmi (Bahasa Inggris)
Comparing the Efficacy and Safety of the EndoZip System and Apollo ESG in Obese Patients
Menerima peserta
Usia 21 hingga 65 · Semua jenis kelamin · Diperbarui 1 Okt 2026 · NCT07090005Safety and Efficacy of ABBV-295 in Adults With Obesity or Overweight With Weight-Related Comorbidities
Menerima pesertaFase 2
Usia 18 hingga 75 · Semua jenis kelamin · Diperbarui 1 Okt 2026 · NCT07752979A Study to Evaluate the Impact of Renal Impairment on the Pharmacokinetics (PK) of Ribupatide
Menerima pesertaFase 1Sukarelawan sehat diterima
Usia 18 hingga 85 · Semua jenis kelamin · Diperbarui 1 Okt 2026 · NCT07793929AMAZE 2: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Type 2 Diabetes Lose Weight
Menerima pesertaFase 3
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 30 Sep 2026 · NCT07533175A Research Study on How Well Cagrilintide and CagriSema Work in Children and Adolescents With Excess Body Weight
Menerima pesertaFase 3
Usia 8 hingga 18 · Semua jenis kelamin · Diperbarui 30 Sep 2026 · NCT07253285Two-Week Stair-Climbing Exercise Snacks and Metabolic Health in Adults With Overweight or Obesity: A Pilot Study
Menerima pesertaSukarelawan sehat diterima
Usia 18 hingga 35 · Semua jenis kelamin · Diperbarui 30 Sep 2026 · NCT07849439A Study to Learn About the Monthly Dosing Study Medicine Called Berobenatide in Adults With Breathing Problems During Sleep and Overweight or Obesity Who Use a Breathing Machine (PAP) (VESPER-OSA 1)
Menerima pesertaFase 3
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 29 Sep 2026 · NCT07823608FAMily-centered WEight Loss for Black Adults (FAM WEL B-ing)
Menerima peserta
Usia 18 hingga 75 · Semua jenis kelamin · Diperbarui 29 Sep 2026 · NCT06724406Study of Olatorepatide in Adult Participants Living With Overweight or Obesity Without Diabetes
Menerima pesertaFase 2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 29 Sep 2026 · NCT07685808AMAZE 9: A Research Study Investigating How Well Zenagamtide Tablets Help People With Excess Body Weight Lose Weight
Menerima pesertaFase 3
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 28 Sep 2026 · NCT07720271A Research Study Investigating How Well the Medicine Zenagamtide Helps People With Excess Body Weight Lose Weight Compared to Semaglutide
Menerima pesertaFase 3
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 28 Sep 2026 · NCT07668414Study to Assess the Effect and Safety of ALV-100 on Maintenance of Weight Loss
Menerima pesertaFase 2
Usia 18 hingga 75 · Semua jenis kelamin · Diperbarui 28 Sep 2026 · NCT07837973A Study of Orforglipron in Participants With Overweight at Risk of Development of Obesity-Related Complications or Progression to Class 1 Obesity
Menerima pesertaFase 3
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 28 Sep 2026 · NCT07794579Study of ALV-100 to Assess Safety, Tolerability, and PK/PD in Overweight/Obese Participants With or Without T2D
Menerima pesertaFase 1
Usia 18 hingga 65 · Semua jenis kelamin · Diperbarui 28 Sep 2026 · NCT07399678Effects of Sucralose on Drug Absorption and Metabolism (The SweetMeds Study)
Menerima pesertaFase 2Sukarelawan sehat diterima
Usia 18 hingga 60 · Wanita · Diperbarui 28 Sep 2026 · NCT03407079A Study to Learn About the Study Medicine Called Berobenatide (PF-08653944) in People With Overweight or Obesity
Menerima pesertaFase 3
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 28 Sep 2026 · NCT07595549Physical and Behavioral Traits of Overweight and Obese Adults
Menerima pesertaStudi observasionalSukarelawan sehat diterima
Usia 18 hingga 100 · Semua jenis kelamin · Diperbarui 28 Sep 2026 · NCT00428987Safety and Drug Concentrations of REGN20934 in Adults With Overweight or Obesity
Menerima pesertaFase 1Sukarelawan sehat diterima
Usia 18 hingga 65 · Semua jenis kelamin · Diperbarui 25 Sep 2026 · NCT07594093A Study to Evaluate Effect of AZD6234 as an Adjunct to Incretin-based Therapies in Adult Participants With Obesity or Overweight With Weight-related Comorbidity With or Without Type 2 Diabetes Mellitus
Menerima pesertaFase 3
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 25 Sep 2026 · NCT07776509A Platform Trial for Pediatric Participants With Obesity or Overweight (LY900040)
Menerima pesertaFase 3
Usia 6 hingga 17 · Semua jenis kelamin · Diperbarui 24 Sep 2026 · NCT06672549Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight
Menerima pesertaFase 3
Usia 18 hingga 70 · Semua jenis kelamin · Diperbarui 24 Sep 2026 · NCT06937099Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study
Menerima pesertaFase 3
Usia 18 hingga 70 · Semua jenis kelamin · Diperbarui 24 Sep 2026 · NCT06937086A Study of Tirzepatide (LY3298176) in Participants With Type 1 Diabetes Mellitus and Overweight or Obesity
Menerima pesertaFase 1
Usia 18 hingga 70 · Semua jenis kelamin · Diperbarui 23 Sep 2026 · NCT07803744A Study of Eloralintide (LY3841136) in Participants With Obesity, or Overweight Without Type 2 Diabetes
Menerima pesertaFase 3
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 22 Sep 2026 · NCT07321886Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity
Menerima pesertaFase 3
Usia 45 hingga 99 · Semua jenis kelamin · Diperbarui 22 Sep 2026 · NCT07037433Dari ClinicalTrials.gov, data diambil 2 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.